BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) In Good Shape, May Continue Higher

BioCryst Pharmaceuticals Inc (BCRX) is trading at $9.49 and appears strong enough to reach as high as $13 (near previous highs) with no particular resistance in sight.

There’s a wide range of undervalued options offered on BioCryst Pharmaceuticals Inc, their profit potential is above average and may well attract short term call buyers. Overall investors are waiting to see if more correction is in store for the Nasdaq and other major indices, but underlying direction stretching beyond 2 weeks is up.